Association of Sociodemographic Factors with Health Protocol Compliance and Metabolic Profile Among Patients with Diabetic Retinopathy
Keywords:
Diabetic Retinopathy, Health Protocol Compliance, Metabolic Profile, Sociodemographic FactorsAbstract
Diabetic retinopathy is a major microvascular complication of diabetes mellitus and is closely related to metabolic disturbances and sociodemographic factors. This study aimed to analyze the association between sociodemographic characteristics, health protocol compliance, and metabolic profile parameters among patients with diabetic retinopathy. An analytical observational study with a cross-sectional design was conducted among 45 diabetic retinopathy patients at two hospitals in Samarinda, Indonesia, during November 2020. Sociodemographic data, serological status, mask types, health protocol compliance scores, and metabolic profile parameters were collected. Female participants slightly predominated (53.3%), and most participants were aged <60 years (71.1%). Educational level was significantly associated with health protocol compliance score (p = 0.008), with higher educational attainment related to better health protocol compliance. Age was significantly associated with HbA1c (p = 0.006), FBG (p = 0.008), and 2hPPBG (p = 0.045). Occupation was significantly associated with TC/HDL (p = 0.008) and LDL/HDL ratios (p = 0.019), while gender was associated with the TC/HDL ratio (p = 0.048). No significant associations were identified between serological status or mask types and metabolic profile parameters. These findings suggest that sociodemographic characteristics, particularly educational level, age, and occupation, may be associated with differences in health behavior and metabolic profiles among patients with diabetic retinopathy.
Downloads
References
Vision Loss Expert Group of the Global Burden of Disease Study and the GBD 2019 Blindness and Vision Impairment Collaborators, “Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-Analysis from 2000 to 2020,” Eye, vol. 38, pp. 2047–2055, 2024, doi: 10.1038/s41433-024-03101-5.
NCD Risk Factor Collaboration, “Global Variation in Diabetes Diagnosis and Prevalence Based on Fasting Glucose and Hemoglobin A1c,” Nat. Med., vol. 29, pp. 2885–2901, 2023, doi: 10.1038/s41591-023-02610-2.
S. A. Medina-Ramirez et al., “Prevalence and Incidence of Diabetic Retinopathy in Patients with Diabetes of Latin America and the Caribbean: A Systematic Review and Meta-Analysis,” PLoS One, vol. 19, no. 4, pp. 1–23, 2024, doi: 10.1371/journal.pone.0296998.
T. G. Wondmeneh and J. A. Mohammed, “Prevalence of Diabetic Retinopathy and Its Associated Risk Factors Among Adults in Ethiopia: A Systematic Review and Meta-Analysis,” Sci. Rep., vol. 14, pp. 1–17, 2024, doi: 10.1038/s41598-024-78596-9.
P. K. Sharma, K. Kumar, A. Dubey, N. Kushwaha, and P. Maravi, “Clinical Study on Association of Diabetic Retinopathy Severity with HbA1c Level,” Indian J. Clin. Exp. Ophthalmol., vol. 10, no. 2, pp. 248–255, 2024, doi: 10.18231/j.ijceo.2024.045.
N. Alswaina, “Association Between HbA1c Levels and the Severity of Diabetic Retinopathy,” Cureus, vol. 16, no. 12, pp. 1–8, 2024, doi: 10.7759/cureus.76395.
M. A. Karimi et al., “Lipid Variability and Risk of Microvascular Complications in Patients with Diabetes: A Systematic Review and Meta-Analysis,” BMC Endocr. Disord., vol. 24, pp. 1–16, 2024, doi: 10.1186/s12902-023-01526-9.
H. Jeong, C. M. Maatouk, M. W. Russell, and R. P. Singh, “Associations Between Lipid Abnormalities and Diabetic Retinopathy Across a Large United States National Database,” Eye, vol. 38, pp. 1870–1875, 2024, doi: 10.1038/s41433-024-03022-3.
M. Rahmati et al., “Factors Affecting Global Adherence for the Uptake of Diabetic Retinopathy Screening: A Systematic Review and Meta-Analysis,” Am. J. Ophthalmol., vol. 268, pp. 94–107, 2024, doi: 10.1016/j.ajo.2024.07.028.
S. Dhandapani, K. Afshan, S. Shreya, C. L. Vincy, V. Yuvaraj, and V. Krithika, “Dietary Intake, Lifestyle Factors, and Metabolic Risk: Insights from Health Check-Ups at a Private Healthcare Facility in Coimbatore, India,” Amerta Nutr., vol. 8, no. 4, pp. 632–641, 2024, doi: 10.20473/amnt.v8i4.2024.632-641.
A. D. Erawati, “Factors Associated with Compliance in Implementing Health Protocols to Prevent COVID-19 in Indonesia: A Cross-Sectional Study,” J. Ners, vol. 17, no. 1, pp. 55–60, 2022, doi: 10.20473/jn.v17i1.25618.
L. Wright, A. Steptoe, and D. Fancourt, “Patterns of Compliance with COVID-19 Preventive Behaviours: A Latent Class Analysis of 20,000 UK Adults,” J Epidemiol Community Heal., vol. 76, pp. 247–253, 2022, doi: 10.1136/jech-2021-216876.
R. A. Ghamri and K. A. Ghamri, “Sociodemographic and Clinical Predictors for COVID-19 Preventive Measures Compliance Among Pregnant Women in Saudi Arabia: A Multicenter Study,” BMC Infect. Dis., vol. 23, pp. 1–11, 2023, doi: 10.1186/s12879-023-08364-z.
World Health Organization (WHO), “Advice for the Public: Coronavirus Disease (COVID-19),” WHO, 2023. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public (accessed Mar. 18, 2023).
World Health Organization (WHO), “Global Surveillance for COVID-19 Caused by Human Infection With COVID-19 Virus.” WHO, pp. 1–4, 2020.
Ministry of Health of the Republic of Indonesia, Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/382/2020 tentang Protokol Kesehatan bagi Masyarakat di Tempat dan Fasilitas Umum dalam Rangka Pencegahan dan Pengendalian Corona Virus Disease 2019 (COVID-19). Indonesia, 2020.
Ministry of Health of the Republic of Indonesia, Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Jakarta: Ministry of Health of the Republic of Indonesia, 2020.
S. Pardhan, R. Raman, A. Biswas, D. Jaisankar, S. Ahluwalia, and R. Sapkota, “Knowledge, Attitude, and Practice of Diabetes in Patients with and Without Sight-Threatening Diabetic Retinopathy from Two Secondary Eye Care Centres in India,” BMC Public Health, vol. 24, pp. 1–10, 2024, doi: 10.1186/s12889-023-17371-3.
F. Nari, J. K. Jun, K. H. O. And, and W. Jeong, “The Association Between Health Literacy and Screening for Disease-Specific Complications Among Community-Dwelling Adults with Diabetes,” Front. Public Heal., vol. 12, pp. 1–7, 2024, doi: 10.3389/fpubh.2024.1418828.
Y. Tang et al., “Analysis of Health Information Needs of Elderly Patients with Chronic Diseases Based on Kano Model: A Descriptive Cross-Sectional Study,” BMC Geriatr., vol. 25, pp. 1–12, 2025, doi: 10.1186/s12877-025-06106-1.
T. Schwarz, A. E. Schmidt, J. Bobek, and J. Ladurner, “Barriers to Accessing Health Care for People with Chronic Conditions: A Qualitative Interview Study,” BMC Health Serv. Res., vol. 22, pp. 1–15, 2022, doi: 10.1186/s12913-022-08426-z.
B. Bhattarai et al., “Structured Counselling and Regular Telephonic Follow-Up to Improve Referral Flow and Compliance in Nepal for Diabetic Retinopathy (SCREEN-D Study): A Randomized Controlled Trial,” BMC Health Serv. Res., vol. 24, pp. 1–9, 2024, doi: 10.1186/s12913-024-10647-3.
I. S. Sadikin, Y. D. Lestari, and A. A. Victor, “The Role of Cadre in the Community on Diabetic Retinopathy Management and Its Challenges in Low-Middle Income Countries: A Scoping Review,” BMC Public Health, vol. 24, pp. 1–16, 2024, doi: 10.1186/s12889-024-17652-5.
M. Zhu, X. Liu, W. Liu, Y. Lu, J. Cheng, and Y. Chen, “β Cell Aging and Age-Related Diabetes,” Aging (Albany. NY)., vol. 13, no. 5, pp. 7691–7706, 2021, doi: 10.18632/aging.202593.
E. M. Everett, “Leveraging Continuous Glucose Monitors to Reduce the Risk of Diabetic Retinopathy,” JAMA Netw. Open, vol. 7, no. 3, pp. 6–7, 2024, doi: 10.1001/jamanetworkopen.2024.0718.
F. Salavatian, N. Hashemi-madani, Z. Emami, Z. Hosseini, K. G. Falavarjani, and M. E. Khamseh, “Improving Diabetic Retinopathy Screening at the Point of Care: Integrating Telemedicine to Overcome Current Challenges,” BMC Ophthalmol., vol. 24, pp. 1–7, 2024, doi: 10.1186/s12886-024-03508-4.
K. Ezhilvendhan, A. Sathiyamoorthy, B. J. Prakash, B. S. Bhava, and A. Shenoy, “Association of Dyslipidemia with Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Hospital‑Based Study,” J. Pharm. Bioallied Sci., vol. 13, no. 2, pp. 1062–1067, 2021, doi: 10.4103/jpbs.jpbs_164_21.
A. R. Bourgonje, M. A. Connelly, H. Van Goor, P. R. Van Dijk, and R. P. F. Dullaart, “Both LDL and HDL Particle Concentrations Associate Positively with an Increased Risk of Developing Microvascular Complications in Patients with Type 2 Diabetes: Lost Protection by HDL (ZODIAC-63),” Cardiovasc. Diabetol., vol. 1, pp. 1–11, 2023, doi: 10.1186/s12933-023-01909-1.
M. F. Ramirez et al., “Sex Differences in Protein Biomarkers and Measures of Fat Distribution,” J. Am. Heart Assoc., vol. 13, pp. 1–13, 2024, doi: 10.1161/JAHA.124.000223.
I. T. De Jacobis et al., “Sex Differences in Lipid Profile and Response to Statin Treatment in Pediatric Patients Affected by Familial Hypercholesterolemia,” Eur. J. Pediatr., vol. 184, pp. 1–6, 2025, doi: 10.1007/s00431-025-06397-x.
B. R. Joshi, T. Yadav, A. K. Amit, and S. Rizal, “Gender Differences in Lipid Profile in Dyslipidemic Patients Visiting Hetauda Hospital,” Med-Phoenix, vol. 9, no. 1, pp. 7–11, 2024, doi: 10.3126/medphoenix.v9i1.67178.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Yuliana Rahmah Retnaningrum, Yuniati, Nur Khoma Fatmawati, Endang Sawitri, Amalia Aswin, Rudi Saputra

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.









